Products

0

Options Newsletter 02-1997

00073
$0.00
In stock
1
Product Details
  • Editorial: Kessler Leaves FDA In A Cloud of Controversy
  • Hydrazine Sulfate: Russian Rocket Fuel or Effective Cancer Therapy?
  • FDA Stops Dr. Springer From Treating His Famous Patients
  • Burzynski On Trial
  • Dr. Coulter Presents Govallo Paper in London and Berlin
  • The Stockholm Protocol
  • BioPro Trial for Prostate Cancer
  • Senator Grassley Vows Support for Medical Treatments Act
Save this product for later
Share by: